High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle

Cerebral blood volume (CBV) measurement complements conventional magnetic resonance imaging (MRI) to indicate pathologies in the central nervous system (CNS). Dynamic susceptibility contrast (DSC) perfusion imaging is limited by low resolution and distortion. Steady-state (SS) imaging may provide hi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cerebral blood flow and metabolism 2013-05, Vol.33 (5), p.780-786
Main Authors: Varallyay, Csanad G, Nesbit, Eric, Fu, Rongwei, Gahramanov, Seymur, Moloney, Brendan, Earl, Eric, Muldoon, Leslie L, Li, Xin, Rooney, William D, Neuwelt, Edward A
Format: Article
Language:English
Subjects:
Blood Volume
Blood Volume Determination - methods
Brain - blood supply
Brain - pathology
Brain Neoplasms - blood supply
Brain Neoplasms - pathology
Central Nervous System Neoplasms - blood supply
Central Nervous System Neoplasms - pathology
Cerebrovascular Circulation
Contrast Media
Gadolinium
Heterocyclic Compounds
Humans
Magnetite Nanoparticles
Organometallic Compounds
Original
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cerebral blood volume (CBV) measurement complements conventional magnetic resonance imaging (MRI) to indicate pathologies in the central nervous system (CNS). Dynamic susceptibility contrast (DSC) perfusion imaging is limited by low resolution and distortion. Steady-state (SS) imaging may provide higher resolution CBV maps but was not previously possible in patients. We tested the feasibility of clinical SS-CBV measurement using ferumoxytol, a nanoparticle blood pool contrast agent. SS-CBV measurement was analyzed at various ferumoxytol doses and compared with DSC-CBV using gadoteridol. Ninety nine two-day MRI studies were acquired in 65 patients with CNS pathologies. The SS-CBV maps showed improved contrast to noise ratios, decreased motion artifacts at increasing ferumoxytol doses. Relative CBV (rCBV) values obtained in the thalamus and tumor regions indicated good consistency between the DSC and SS techniques when the higher dose (510 mg) ferumoxytol was used. The SS-CBV maps are feasible using ferumoxytol in a clinical dose of 510 mg, providing higher resolution images with comparable rCBV values to the DSC technique. Physiologic imaging using nanoparticles will be beneficial in visualizing CNS pathologies with high vascularity that may or may not correspond with blood–brain barrier abnormalities.
ISSN:0271-678X
1559-7016
1559-7016
DOI:10.1038/jcbfm.2013.36